Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

Group 1 - Lexicon Pharmaceuticals will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on June 5 at 12:50 p.m. ET [1] - The event will be accessible live and as a replay on the Company's website [1] Group 2 - Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [2] - The Genome5000™ program has enabled Lexicon to study nearly 5,000 genes, identifying over 100 protein targets with significant therapeutic potential [2] - The company has advanced multiple medicines to market and has a pipeline of drug candidates in various stages of development for conditions such as heart failure, neuropathic pain, obesity, cardiology, and diabetes [2]